KATIE ADAMS: Open Payments
NPI 1619737210 · COOS BAY, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$254 in 3 payments from 3 companies in 2025. Trend: 2023 $0 · 2024 $179 · 2025 $254
Food & beverage: $254
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 1 | $117 |
| Otsuka America Pharmaceutical, Inc. | 1 | $106 |
| Janssen Pharmaceuticals, Inc | 1 | $31 |
Products named: INGREZZA, REXULTI, INVEGA SUSTENNA.
Industry payments across OR — which companies pay providers there.
